Patents by Inventor Didier NOURRISSON

Didier NOURRISSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition containing a somatostatin analogue for radiopharmaceutical use
    Patent number: 12329830
    Abstract: The present invention relates to a somatostatin analogue composition for radiopharmaceutical use, in particular for diagnostic or therapeutic use. More specifically the somatostatin analogue is a receptor-selective somatostatin peptide antagonist.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: June 17, 2025
    Assignee: Ariceum Therapeutics GmbH
    Inventors: Romain Bejot, Bilal Karaaoui, Didier Kubiak, Anne-Claire Le Meur, Didier Nourrisson, Anne Petit, Joel Richard, Camille Toulisse
  • Composition Containing a Somatostatin Analogue for Radiopharmaceutical Use
    Publication number: 20210128758
    Abstract: The present invention relates to a somatostatin analogue composition for radiopharmaceutical use, in particular for diagnostic or therapeutic use. More specifically the somatostatin analogue is a receptor-selective somatostatin peptide antagonist.
    Type: Application
    Filed: June 20, 2019
    Publication date: May 6, 2021
    Inventors: Romain Bejot, Bilal Karaaouil, Didier Kubiak, Anne-Claire Le Meur, Didier Nourrisson, Anne Petit, Joel Richard, Camille Toulisse
  • AQUEOUS GELLING COMPOSITIONS OF SOLUBLE ACTIVE PHARMACEUTICAL PEPTIDES PROVIDING MODIFIED RELEASE
    Publication number: 20170035884
    Abstract: An aqueous pharmaceutical composition comprising a peptide and one or more water-soluble or water-dispersible gelling agents.
    Type: Application
    Filed: September 22, 2016
    Publication date: February 9, 2017
    Inventors: Marie-Madeleine Baronnet, Joël Richard, Nathalie Mondoly, Didier Nourrisson
  • Sustained-release composition containing peptides as active ingredient
    Patent number: 9415012
    Abstract: The present invention relates to a sustained-release drug composition consisting essentially of microparticles of a peptide as the active substance and a biocompatible water-soluble polymer, in particular peptide as meianocortin receptor ligand. The present invention relates also to an injection formulation comprising the sustained-release drug composition suspended in an injection medium.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: August 16, 2016
    Assignee: IPSEN PHARMA S.A.S.
    Inventors: Joël Richard, Faïza Laredj, Marie-Madeleine Baronnet, Didier Nourrisson, Jeremiah Harnett, Béatrice Hacher, Nathalie Mondoly, Laurent Bertocchi
  • Aqueous Gelling Compositions of Soluble Active Pharmaceutical Peptides Providing Modified Release
    Publication number: 20150157719
    Abstract: The present invention relates to an aqueous pharmaceutical composition comprising a peptide as the active ingredient, and one or more water-soluble or water-dispersible gelling agents.
    Type: Application
    Filed: June 13, 2013
    Publication date: June 11, 2015
    Inventors: Marie-Madeleine Baronnet, Joël Richard, Nathalie Mondoly, Didier Nourrisson
  • SUSTAINED-RELEASE COMPOSITION CONTAINING PEPTIDES AS ACTIVE INGREDIENT
    Publication number: 20140127303
    Abstract: The present invention relates to a sustained-release drug composition consisting essentially of microparticles of a peptide as the active substance and a biocompatible water-soluble polymer, in particular peptide as meianocortin receptor ligand. The present invention relates also to an injection formulation comprising the sustained-release drug composition suspended in an injection medium.
    Type: Application
    Filed: June 13, 2012
    Publication date: May 8, 2014
    Applicant: IPSEN PHARMA S.S.A.
    Inventors: Joël Richard, Faïza Laredj, Maire-Madeleine Baronnet, Didier Nourrisson, Jeremiah Harnett, Béatrice Hacher, Nathalie Mondoly, Laurent Bertocchi
  • Liquid and Freeze Dried Formulations
    Publication number: 20110034399
    Abstract: The present invention relates to stable parenteral formulations comprising a new class of compounds, which is a non proteinic compound, a method for preparing such formulations as well as the use of certain compounds for stabilizing these formulations.
    Type: Application
    Filed: April 3, 2009
    Publication date: February 10, 2011
    Applicant: IPSEN PHARMA S.A.S.
    Inventor: Didier NOURRISSON